Article info
PDFLaw, ethics and medicine
Paper
National Institute for Health and Clinical Excellence appraisal and ageism
- Correspondence to Professor Peter Littlejohns, NICE, Midicity Place, 71 High Holborn, London SW4 9HF, UK; peter.littlejohns{at}nice.org.uk
Citation
National Institute for Health and Clinical Excellence appraisal and ageism
Publication history
- Received July 28, 2011
- Revised November 25, 2011
- Accepted November 28, 2011
- First published January 2, 2012.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Other content recommended for you
- National Institute for Clinical Excellence and its value judgments
- NICE’s end of life decision making scheme: impact on population health
- Not a NICE fallacy: a reply to Dr Quigley
- Ageism and equality
- Cost-effectiveness of insulin pumps compared with multiple daily injections both provided with structured education for adults with type 1 diabetes: a health economic analysis of the Relative Effectiveness of Pumps over Structured Education (REPOSE) randomised controlled trial
- Intermittent self catheterisation with hydrophilic, gel reservoir, and non-coated catheters: a systematic review and cost effectiveness analysis
- A guide to health economic evaluations
- NICE rules that drug used in advanced liver cancer is not cost effective for the NHS
- Tilt testing is more cost-effective than implantable loop recorder monitoring as a means of directing pacing therapy in people with recurrent episodes of suspected vasovagal syncope that affect their quality of life or present a high risk of injury
- NICE discrimination